October 2018 Market Review
December 27, 2018 1:16 pm Leave your thoughtsIt is a long established fact that a reader will be distracted by the readable content of a page when looking at its layout. The point of using Lorem
Author Archives for Debbie Wibowo
October 2018 Market Commentary
December 26, 2018 12:20 pm Leave your thoughtsLorem Ipsum is simply dummy text of the printing and typesetting industry. Lorem Ipsum has been the industry's standard dummy text ever since
August 2018 Market Review
December 24, 2018 2:16 pm Leave your thoughtsFollowing is a summary of the markets and our funds’ performance for the month of August 2018, provided by our Chief Investment Strategist David A. Klassen.
July 2018 Market Review
December 20, 2018 11:10 am Comments Off on July 2018 Market ReviewLorem Ipsum is simply dummy textLorem Ipsum is simply dummy textLorem Ipsum is simply dummy textLorem Ipsum is simply dummy textLorem Ipsum is simply
Q2 2018 Market and Performance Update
December 18, 2018 2:21 pm Leave your thoughtsFollowing is a summary of the markets and our funds’ performance for the second quarter of 2018, provided by our Chief Investment Strategist David Klassen.
Social Issues Proxy Voting Guidelines
December 1, 2018 4:26 pm Leave your thoughtsThe UCF Social Issues Proxy Voting Guidelines.
Introduction to Charitable Gift Annuities
November 29, 2018 8:02 pm Leave your thoughtsMilly Hernandez, Client Service Team Leader and Planned Giving Associate and Don Hill, President, Don Hill Consulting, explain the key aspects of Charitable Gift Annuities, one of the most popular ways to make a planned gift.
April 2018 Market Review
May 16, 2018 2:23 pm Leave your thoughtsFollowing is a summary of the markets and our funds’ performance for the month of April 2018, provided by our Chief Investment Strategist David A. Klassen.
Women Investing Today – Seeking Justice in Our Financial Lives
May 11, 2018 2:28 pm Leave your thoughts21% of Abbvie Shareholders Favor Report on How Drug Pricing Risks are Integrated Into Exec Incentive Programs
May 4, 2018 2:33 pm Leave your thoughtsAt today’s annual shareholder meeting for Abbvie a first-time shareholder proposal questioning the links between executive compensation packages and drug price increases received a solid show of support from investors, signaling to the board of directors that this issue is key to investor confidence about the long-term sustainability of the company.